List of Excipients in API eszopiclone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing eszopiclone
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Rebel Distributors Corp | LUNESTA | eszopiclone | 21695-225 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | |
| Rebel Distributors Corp | LUNESTA | eszopiclone | 21695-225 | CELLULOSE, MICROCRYSTALLINE | |
| Rebel Distributors Corp | LUNESTA | eszopiclone | 21695-225 | CROSCARMELLOSE SODIUM | |
| Rebel Distributors Corp | LUNESTA | eszopiclone | 21695-225 | HYPROMELLOSE 2910 | |
| Rebel Distributors Corp | LUNESTA | eszopiclone | 21695-225 | LACTOSE MONOHYDRATE | |
| Rebel Distributors Corp | LUNESTA | eszopiclone | 21695-225 | MAGNESIUM STEARATE | |
| Rebel Distributors Corp | LUNESTA | eszopiclone | 21695-225 | POLYETHYLENE GLYCOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing eszopiclone
Detailed excipient profiles for eszopiclone
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
eszopiclone drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
eszopiclone drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: ANHYDROUS LACTOSE
eszopiclone drug variants containing ANHYDROUS LACTOSE
eszopiclone drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
eszopiclone drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
eszopiclone drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
eszopiclone drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
eszopiclone drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
eszopiclone drug variants containing CELLULOSE, MICROCRYSTALLINE
eszopiclone drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
eszopiclone drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| DirectRX | eszopiclone | 61919-323 |
| >Company | >Ingredient | >NDC |
eszopiclone drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
eszopiclone drug variants containing CROSCARMELLOSE SODIUM
eszopiclone drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
eszopiclone drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
eszopiclone drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
eszopiclone drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | eszopiclone | 0093-5537 |
| >Company | >Ingredient | >NDC |
eszopiclone drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2
eszopiclone drug variants containing FD&C BLUE NO. 2
eszopiclone drug variants not containing FD&C BLUE NO. 2
Excipient focus: FERRIC OXIDE RED
eszopiclone drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | eszopiclone | 0378-5270 |
| Aphena Pharma Solutions - Tennessee LLC | eszopiclone | 43353-200 |
| A-S Medication Solutions | eszopiclone | 50090-2606 |
| Golden State Medical Supply Inc | eszopiclone | 60429-632 |
| >Company | >Ingredient | >NDC |
eszopiclone drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
eszopiclone drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | eszopiclone | 0378-5270 |
| Aphena Pharma Solutions - Tennessee LLC | eszopiclone | 43353-200 |
| A-S Medication Solutions | eszopiclone | 50090-2606 |
| Golden State Medical Supply Inc | eszopiclone | 60429-632 |
| >Company | >Ingredient | >NDC |
eszopiclone drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
eszopiclone drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | eszopiclone | 0378-5270 |
| Aphena Pharma Solutions - Tennessee LLC | eszopiclone | 43353-200 |
| A-S Medication Solutions | eszopiclone | 50090-2606 |
| Golden State Medical Supply Inc | eszopiclone | 60429-632 |
| >Company | >Ingredient | >NDC |
eszopiclone drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYPROMELLOSE
eszopiclone drug variants containing HYPROMELLOSE
eszopiclone drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
eszopiclone drug variants containing HYPROMELLOSE 2910
eszopiclone drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
eszopiclone drug variants containing HYPROMELLOSES
eszopiclone drug variants not containing HYPROMELLOSES
Excipient focus: INDIGOTINDISULFONATE SODIUM
eszopiclone drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | eszopiclone | 71610-409 |
| >Company | >Ingredient | >NDC |
eszopiclone drug variants not containing INDIGOTINDISULFONATE SODIUM
Excipient focus: LACTOSE MONOHYDRATE
eszopiclone drug variants containing LACTOSE MONOHYDRATE
eszopiclone drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
eszopiclone drug variants containing MAGNESIUM STEARATE
eszopiclone drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| DIRECT RX | eszopiclone | 61919-587 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE
eszopiclone drug variants containing MICROCRYSTALLINE CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | eszopiclone | 43353-200 |
| >Company | >Ingredient | >NDC |
eszopiclone drug variants not containing MICROCRYSTALLINE CELLULOSE
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
eszopiclone drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | eszopiclone | 31722-855 |
| Proficient Rx LP | eszopiclone | 82804-159 |
| >Company | >Ingredient | >NDC |
eszopiclone drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POLYDEXTROSE
eszopiclone drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| DIRECT RX | eszopiclone | 61919-462 |
| Bryant Ranch Prepack | eszopiclone | 71335-0784 |
| >Company | >Ingredient | >NDC |
eszopiclone drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
eszopiclone drug variants containing POLYETHYLENE GLYCOL
eszopiclone drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
eszopiclone drug variants containing POLYETHYLENE GLYCOL 3350
eszopiclone drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
eszopiclone drug variants containing POLYETHYLENE GLYCOL 400
eszopiclone drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 6000
eszopiclone drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | eszopiclone | 0093-5537 |
| >Company | >Ingredient | >NDC |
eszopiclone drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
eszopiclone drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| DIRECT RX | eszopiclone | 61919-462 |
| Bryant Ranch Prepack | eszopiclone | 71335-0784 |
| >Company | >Ingredient | >NDC |
eszopiclone drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
eszopiclone drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | eszopiclone | 53217-150 |
| Aidarex Pharmaceuticals LLC | eszopiclone | 53217-151 |
| Physicians Total Care Inc | eszopiclone | 54868-5439 |
| Bryant Ranch Prepack | eszopiclone | 63629-3142 |
| >Company | >Ingredient | >NDC |
eszopiclone drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
eszopiclone drug variants containing POLYSORBATE 80
eszopiclone drug variants not containing POLYSORBATE 80
Excipient focus: POVIDONE
eszopiclone drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | eszopiclone | 43063-795 |
| Lupin Pharmaceuticals Inc | eszopiclone | 68180-322 |
| REMEDYREPACK INC | eszopiclone | 70518-2979 |
| DIRECT RX | eszopiclone | 72189-099 |
| >Company | >Ingredient | >NDC |
eszopiclone drug variants not containing POVIDONE
Excipient focus: SILICON DIOXIDE
eszopiclone drug variants containing SILICON DIOXIDE
eszopiclone drug variants not containing SILICON DIOXIDE
Excipient focus: STARCH, CORN
eszopiclone drug variants containing STARCH, CORN
eszopiclone drug variants not containing STARCH, CORN
Excipient focus: TITANIUM DIOXIDE
eszopiclone drug variants containing TITANIUM DIOXIDE
eszopiclone drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
eszopiclone drug variants containing TRIACETIN
eszopiclone drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
